ALCOX:EPA
NicOx SA
0,31 €
arrow_downward
-0,97%(-0,0030) 1D
12-окт., 15:48:15 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
29,76 млн
Avg. vol.
164,58 миң
Volume
99,31 миң
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
29,76 млн
Avg. vol.
164,58 миң
Volume
99,31 миң
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
News stories
From web sources and news partners
Yahoo Finance
·
40 мүнөт мурун
A handful of tech stocks are masking an ugly S&P 500 problem
Macau Business
·
8 мүнөт мурун
SSA Commissioner Headlines Columbus Day at the NYSE: NYSE Content Update
GlobeNewswire
·
46 мүнөт мурун
Stewards Inc. to Ring Nasdaq Opening Bell on Oct. 14, Celebrating Company's Next Chapter
24/7 Wall St.
·
32 мүнөт мурун
Stock Market Today: S&P 500 Futures Pause Near Record Highs as Oil Rises Ahead of Bank Earnings
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersВальбон, Прованс-Альп-Кот д'Азур, Франция
Sector-
Websitenicox.com